The efficacy of adjunctive balloon postdilation at the overlapping site of drug-eluting stent in diffuse long coronary lesion

Coronary Artery Disease

Volumn 19, Issue 3, 2008, Pages 211-215

  Suh, Soon Yong ^a   Rha, Seung Woon ^a   Na, Jin Oh ^a   Choi, Cheol Ung ^a   Kim, Jin Won ^a   Kim, Eung Ju ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Adjunctive balloon; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; HEPARIN; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INJURY; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; Q WAVE; RESTENOSIS; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 42349103492     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f6dfe0     Document Type: Article

References (11)

1. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann EJ, Schomig A. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999; 83:1617-1622.
2. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 2004; 93:826-829.
3. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent Underexpansion and residual reference segment stenosis are related to stent thrombosis after Sirolimus-eluting stent implantation. J Am Coll Cardiol 2005; 45:995-998.
4. Schwartz RS, Elderman ER, Carter A, Chronos N, Rogers C, Robinson KA, et al. Drug eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 2002; 106:1867-1873.
5. Munoz JS, Abizaid A, Mintz GS, Albertal M, Abizaid AS, Feres F, et al. Intravascular ultrasound study of effects of overlapping Sirolimus-eluting stents. Am J Cardiol 2004; 93:470-473.
6. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005; 45:1570-1573.
7. Lee SH, Jang YS, Oh SJ, Park KJ, Moon YS, Min JW, et al. Overlapping vs. one long stenting in long coronary lesions. Catheter Cardiovasc Interv 2004; 62:298-302.
8. Cheneau E, Satler LF, Escolar E, Suddath WO, Kent KM, Weissman NJ, Waksman R. Underexpansion of Sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 2005; 65:222-226.
9. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AHM, Bonneau HN, et al. Impact of final stent dimensions on long-term results following Sirolimus-eluting stent implantation. J Am Coll Cardiol 2004; 43:1959-1963.
10. Blackman DJ, Porto I, Shirodaria C, Channon KM, Banning AP. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol 2004; 94:922-925.
11. Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition. Circulation 2005; 111:2958-2965.